OM

Opaleye Management Portfolio holdings

AUM $494M
This Quarter Return
-8.12%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.29%
AUM
$116M
AUM Growth
+$116M
Cap. Flow
-$4.86M
Cap. Flow %
-4.19%
Top 10 Hldgs %
74.92%
Holding
39
New
9
Increased
10
Reduced
5
Closed
12

Top Buys

1
CMRX
Chimerix, Inc.
CMRX
$5.57M
2
CLVS
Clovis Oncology, Inc.
CLVS
$5.37M
3
AGIO icon
Agios Pharmaceuticals
AGIO
$5.27M
4
INSY
Insys Therapeutics, Inc.
INSY
$2.68M
5
MZOR
Mazor Robotics Ltd.
MZOR
$2.11M

Top Sells

1
OMER icon
Omeros
OMER
$6.04M
2
NPSP
NPS PHARMACEUTICALS INC
NPSP
$4.49M
3
NVDQ
Novadaq Technologies Inc.
NVDQ
$4.12M
4
LAB icon
Standard BioTools
LAB
$3.97M
5
EPZM
Epizyme, Inc
EPZM
$2.63M

Sector Composition

1 Healthcare 70.08%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CMRX
1
DELISTED
Chimerix, Inc.
CMRX
$17.3M 14.94% 790,000 +254,000 +47% +$5.57M
TVTX icon
2
Travere Therapeutics
TVTX
$1.56B
$14.3M 12.31% 1,216,400 +63,170 +5% +$742K
ARIA
3
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$10.6M 9.12% 1,660,000 -10,000 -0.6% -$63.7K
PCYC
4
DELISTED
PHARMACYCLICS INC
PCYC
$8.97M 7.73% 100,000 -15,000 -13% -$1.35M
GNMK
5
DELISTED
GenMark Diagnostics, Inc
GNMK
$6.77M 5.83% 500,000 +65,000 +15% +$879K
BIND
6
DELISTED
BIND THERAPEUTICS INC
BIND
$6.49M 5.59% 492,000 +65,000 +15% +$857K
NSPR icon
7
InspireMD
NSPR
$102M
$6.43M 5.54% 2,180,000 +30,000 +1% +$88.5K
CEMP
8
DELISTED
Cempra, Inc.
CEMP
$5.42M 4.67% 504,800 +24,800 +5% +$266K
CLVS
9
DELISTED
Clovis Oncology, Inc.
CLVS
$5.37M 4.63% +130,000 New +$5.37M
AGIO icon
10
Agios Pharmaceuticals
AGIO
$2.19B
$5.27M 4.54% +115,000 New +$5.27M
CSII
11
DELISTED
Cardiovascular Systems, Inc.
CSII
$4.21M 3.63% 135,000 – –
CPRX icon
12
Catalyst Pharmaceutical
CPRX
$2.52B
$3.49M 3.01% 1,378,584 – –
INSY
13
DELISTED
Insys Therapeutics, Inc.
INSY
$2.68M 2.31% +85,800 New +$2.68M
TTPH
14
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$2.29M 1.97% 169,700 +9,700 +6% +$131K
MZOR
15
DELISTED
Mazor Robotics Ltd.
MZOR
$2.11M 1.82% +120,000 New +$2.11M
RARE icon
16
Ultragenyx Pharmaceutical
RARE
$2.89B
$2.02M 1.74% +45,000 New +$2.02M
EVOK icon
17
Evoke Pharma
EVOK
$8.49M
$1.96M 1.69% 242,500 +9,100 +4% +$73.6K
SCTL
18
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$1.76M 1.52% +220,000 New +$1.76M
CELGZ
19
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
$1.72M 1.48% 660,000 – –
KPTI icon
20
Karyopharm Therapeutics
KPTI
$61.7M
$1.4M 1.2% +30,000 New +$1.4M
BLRX
21
BioLineRX
BLRX
$16.2M
$1.35M 1.17% 650,000 -801,000 -55% -$1.67M
CDXS icon
22
Codexis
CDXS
$246M
$1.2M 1.03% 820,000 +121,700 +17% +$178K
CPXX
23
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$1.07M 0.93% 338,402 +13,402 +4% +$42.5K
KBIO
24
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$730K 0.63% 320,000 -225,000 -41% -$513K
ALNY icon
25
Alnylam Pharmaceuticals
ALNY
$58.5B
$455K 0.39% +7,200 New +$455K
1
2